НовостиBenzingaHC Wainwright & Co. Reiterates Buy on Rapport Therapeutics, Maintains $66 Price Target HC Wainwright & Co. Reiterates Buy on Rapport Therapeutics, Maintains $66 Price Target Benzinga 2026.10.20 16:32 (GMT+0) Открыть на Benzinga Другие новости